Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05109923 · ClinicalTrials.gov registry record · NA
Onnit Labs New Mood Supplementation in Healthy College Students
A NA study, sponsored by University of Idaho.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT05109923: Completed NA study, sponsored by University of Idaho.
NCT05109923 is a NA study that has completed, run by University of Idaho. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05109923, a NA study, has completed, sponsored by University of Idaho.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the effectiveness of ONNIT Lab's New Mood™ dietary supplement in supporting optimal mood balance and reducing daily stress among collegiate-aged men and women. To be considered for this study, the participant must meet the following criteria: (1) current undergraduate student at the University of Idaho between 18-24 years of age, (2) have no known allergies to the ingredients of New Mood™ (Niacin, Vitamin B6, Magnesium, Valerian Extract, Lemon Balm Extract, L-Tryptophan. 5-Hydroxytryptophan, and Inositol) or the placebo (rice bran and maltodextrin), (3) not currently taking any mood/sleep supplementation or medications, (4) not currently seeking therapy or diagnosed with a psychological disorder, (5) not regularly using cigarettes, marijuana, or other illicit drugs, and (6) not pregnant or breastfeeding.
Primary Outcome
Three salivary cortisol measurements to determine cortisol awakening response (mg/dL) from baseline to 8 weeks
Interventions
- DIETARY_SUPPLEMENT Placebo Supplement
- DIETARY_SUPPLEMENT Multi-Ingredient Herbal Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2018-09-10 |
| Est. Completion | 2019-08-02 |
| Phase | NA |
What the finished NCT05109923 record still lists
NCT05109923 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo Supplement is the first listed.
NCT05109923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05109923 about?
NCT05109923 is a clinical study titled "Onnit Labs New Mood Supplementation in Healthy College Students". The primary purpose of this study is to assess the effectiveness of ONNIT Lab's New Mood™ dietary supplement in supporting optimal mood balance and reducing daily stress among collegiate-aged men and women. To be considered for this study, the participant must meet the following criteria: (1) curren...
What is the current status of trial NCT05109923?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2018-09-10. Estimated completion is 2019-08-02.
What interventions are being tested in trial NCT05109923?
The interventions under investigation include: Placebo Supplement (DIETARY_SUPPLEMENT), Multi-Ingredient Herbal Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05109923?
This trial is sponsored by University of Idaho, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05109923's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI